Parallel Advisors, LLC Beyond Spring Inc. Transaction History

Parallel Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 20, 2024	SELL	$0.75 - $1.16 $604 - $934	-806 Reduced 50.0%	806 $0
Q3 2023 Nov 13, 2023	SELL	$0.75 - $1.16 $604 - $934	-806 Reduced 50.0%	806 $0
Q2 2023 May 20, 2024	BUY	$0.89 - $1.39 $1,434 - $2,240	1,612 New	1,612 $1,000
Q2 2023 Aug 04, 2023	BUY	$0.89 - $1.39 $1,434 - $2,240	1,612 New	1,612 $1,000
Q4 2021 Jan 20, 2022	SELL	$4.02 - $16.84 $643 - $2,694	-160 Closed	0 $0

Q3 2021 Nov 02, 2021	SELL	$9.26 - $31.31 $305 - $1,033	-33 Reduced 17.1%	160 $3,000
Q2 2021 Aug 06, 2021	BUY	$9.37 - $12.12 $1,808 - $2,339	193 New	193 $2,000

5.44M

30.3K

1.8K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $95.4M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.